chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: sore throat; runny nose; terrible headache off and on; nauseated like I was going to pass out; muscle body ache, it's like somebody beat me with a bat and put me back in bed; fatigue / it's like somebody beat me with a bat and put me back in bed; hurt my body to walk, like every bone had been beat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (hurt my body to walk, like every bone had been beat), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on) and NAUSEA (nauseated like I was going to pass out) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (hurt my body to walk, like every bone had been beat). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on), NAUSEA (nauseated like I was going to pass out), MYALGIA (muscle body ache, it's like somebody beat me with a bat and put me back in bed) and FATIGUE (fatigue / it's like somebody beat me with a bat and put me back in bed). At the time of the report, PAIN (hurt my body to walk, like every bone had been beat), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on), NAUSEA (nauseated like I was going to pass out), MYALGIA (muscle body ache, it's like somebody beat me with a bat and put me back in bed) and FATIGUE (fatigue / it's like somebody beat me with a bat and put me back in bed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rhinorrhoea
Clinical narrative: sore throat; runny nose; terrible headache off and on; nauseated like I was going to pass out; muscle body ache, it's like somebody beat me with a bat and put me back in bed; fatigue / it's like somebody beat me with a bat and put me back in bed; hurt my body to walk, like every bone had been beat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (hurt my body to walk, like every bone had been beat), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on) and NAUSEA (nauseated like I was going to pass out) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (hurt my body to walk, like every bone had been beat). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on), NAUSEA (nauseated like I was going to pass out), MYALGIA (muscle body ache, it's like somebody beat me with a bat and put me back in bed) and FATIGUE (fatigue / it's like somebody beat me with a bat and put me back in bed). At the time of the report, PAIN (hurt my body to walk, like every bone had been beat), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny nose), HEADACHE (terrible headache off and on), NAUSEA (nauseated like I was going to pass out), MYALGIA (muscle body ache, it's like somebody beat me with a bat and put me back in bed) and FATIGUE (fatigue / it's like somebody beat me with a bat and put me back in bed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Pruritus
Clinical narrative: Numbness and Tingling in hands and feet; Numbness and Tingling in hands and feet; Itching; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness and Tingling in hands and feet), PARAESTHESIA (Numbness and Tingling in hands and feet) and PRURITUS (Itching) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (IV Dye). Concomitant products included HYDROCHLOROTHIAZIDE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), GABAPENTIN and LETROZOLE for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) UNK dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness and Tingling in hands and feet), PARAESTHESIA (Numbness and Tingling in hands and feet) and PRURITUS (Itching). At the time of the report, HYPOAESTHESIA (Numbness and Tingling in hands and feet), PARAESTHESIA (Numbness and Tingling in hands and feet) and PRURITUS (Itching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment includes Benadryl.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Mass, Muscle twitching, Pruritus, Urticaria
Clinical narrative: I itched and got little pain sparks all over my body; Hard lumps/bumpy feel; Extremely itchy; Nerve endings in her arms and legs were pulsating; Hives all over my body; arms, legs, chest, torso, back; Face was flushed; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Hard lumps/bumpy feel), PRURITUS (Extremely itchy), MUSCLE TWITCHING (Nerve endings in her arms and legs were pulsating), PRURITUS (I itched and got little pain sparks all over my body) and FLUSHING (Face was flushed) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FLUSHING (Face was flushed). On 07-Mar-2021, the patient experienced MASS (Hard lumps/bumpy feel), PRURITUS (Extremely itchy) and MUSCLE TWITCHING (Nerve endings in her arms and legs were pulsating). 07-Mar-2021, the patient experienced URTICARIA (Hives all over my body; arms, legs, chest, torso, back). On 15-Mar-2021, the patient experienced PRURITUS (I itched and got little pain sparks all over my body). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 UNK; CORTISONE (topical) at a dose of 1 UNK and PREDNISONE on 11-Mar-2021 at a dose of 1 UNK. At the time of the report, MASS (Hard lumps/bumpy feel), PRURITUS (Extremely itchy) and MUSCLE TWITCHING (Nerve endings in her arms and legs were pulsating) was resolving, PRURITUS (I itched and got little pain sparks all over my body) had resolved and FLUSHING (Face was flushed) and URTICARIA (Hives all over my body; arms, legs, chest, torso, back) had not resolved.            No Medical history and Lab history are reported Patient stated that he is not using concomitant medications as of now.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Email Describes SE for both vaccines. Dose 1 case will be created.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Ear pain, Headache, Muscle spasms
Clinical narrative: waxing and waning muscle cramping; worse at night like cramping felt like achy; ear aches; dizziness; muscle aches; joint pain in my hands; headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness) and MYALGIA (muscle aches) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included DIGOXIN, METOPROLOL TARTRATE (METOPROLOL XL) and APIXABAN (ELIQUIS) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness), MYALGIA (muscle aches), ARTHRALGIA (joint pain in my hands) and HEADACHE (headache). At the time of the report, MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness), MYALGIA (muscle aches), ARTHRALGIA (joint pain in my hands) and HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: waxing and waning muscle cramping; worse at night like cramping felt like achy; ear aches; dizziness; muscle aches; joint pain in my hands; headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness) and MYALGIA (muscle aches) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included DIGOXIN, METOPROLOL TARTRATE (METOPROLOL XL) and APIXABAN (ELIQUIS) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness), MYALGIA (muscle aches), ARTHRALGIA (joint pain in my hands) and HEADACHE (headache). At the time of the report, MUSCLE SPASMS (waxing and waning muscle cramping), MUSCLE SPASMS (worse at night like cramping felt like achy), EAR PAIN (ear aches), DIZZINESS (dizziness), MYALGIA (muscle aches), ARTHRALGIA (joint pain in my hands) and HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Hot flush, Vaccination site rash
Clinical narrative: rash around the injection site; was flushed; face and ears were warm to touch; face and ears were bright red; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (was flushed), HOT FLUSH (face and ears were warm to touch), ERYTHEMA (face and ears were bright red) and VACCINATION SITE RASH (rash around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypothyroidism, Pollen allergy and Grass allergy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FLUSHING (was flushed), HOT FLUSH (face and ears were warm to touch) and ERYTHEMA (face and ears were bright red). On 09-Mar-2021, the patient experienced VACCINATION SITE RASH (rash around the injection site). On 02-Mar-2021, FLUSHING (was flushed) had resolved. At the time of the report, HOT FLUSH (face and ears were warm to touch), ERYTHEMA (face and ears were bright red) and VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes medication for hypertension and hypothyroidism. Treatment with Benadryl  was provided for rash.   This case was linked to MOD-2021-110249 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event outcome provided.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided. No concomitant medication were provided.   This case was linked to MOD-2021-039319 (Patient Link).; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, lot #unknown  with no associated AEs.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching; pretty big rash on her arm (arm of the injection); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and RASH (pretty big rash on her arm (arm of the injection)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D9A21A O 09A21A (patient not sure)) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (Itching) and RASH (pretty big rash on her arm (arm of the injection)). At the time of the report, PRURITUS (Itching) and RASH (pretty big rash on her arm (arm of the injection)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment for the event included diphenhydramine. Treatment Benadryl
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in toes; Tingling sensation in toes; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in toes) and PARAESTHESIA (Tingling sensation in toes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: CIPROFLOXACIN (ciprofloxacin 500 mg). Concomitant products included THIOTHIXENE HCL and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness in toes) and PARAESTHESIA (Tingling sensation in toes). At the time of the report, HYPOAESTHESIA (Numbness in toes) and PARAESTHESIA (Tingling sensation in toes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Gait disturbance, Headache, Hyperhidrosis
Clinical narrative: Staggering all over the place; Weak; Cold; Sweating; Severe headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating) and HEADACHE (Severe headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating), HEADACHE (Severe headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating), HEADACHE (Severe headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Staggering all over the place; Weak; Cold; Sweating; Severe headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating) and HEADACHE (Severe headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating), HEADACHE (Severe headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, GAIT DISTURBANCE (Staggering all over the place), ASTHENIA (Weak), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (Sweating), HEADACHE (Severe headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: she felt her heart was pounding and became short of breath for 2 minutes; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (she felt her heart was pounding and became short of breath for 2 minutes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015m20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) and VITAMINS NOS for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced DYSPNOEA (she felt her heart was pounding and became short of breath for 2 minutes). On 22-Feb-2021, DYSPNOEA (she felt her heart was pounding and became short of breath for 2 minutes) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature abnormal, Fatigue, Feeling abnormal, Headache
Clinical narrative: terrible headache; very tired; aches like she had the flu all day; temp 102.1°F; didn't feel well; very nauseated; sore arm; hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), PAIN (hurt) and NAUSEA (very nauseated) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included LOSARTAN POTASSIUM for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PAIN (hurt). On 05-Mar-2021, the patient experienced BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), NAUSEA (very nauseated), FATIGUE (very tired) and PAIN (aches like she had the flu all day). On 06-Mar-2021, the patient experienced HEADACHE (terrible headache). The patient was treated with IBUPROFEN for Fever and Ache, at an unspecified dose and frequency. On 06-Mar-2021, FATIGUE (very tired) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), PAIN (hurt), NAUSEA (very nauseated) and PAIN (aches like she had the flu all day) outcome was unknown and HEADACHE (terrible headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 102.1 (High) 102.1°F. On 06-Mar-2021, Body temperature: 100 100 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity
Clinical narrative: terrible headache; very tired; aches like she had the flu all day; temp 102.1°F; didn't feel well; very nauseated; sore arm; hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), PAIN (hurt) and NAUSEA (very nauseated) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included LOSARTAN POTASSIUM for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PAIN (hurt). On 05-Mar-2021, the patient experienced BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), NAUSEA (very nauseated), FATIGUE (very tired) and PAIN (aches like she had the flu all day). On 06-Mar-2021, the patient experienced HEADACHE (terrible headache). The patient was treated with IBUPROFEN for Fever and Ache, at an unspecified dose and frequency. On 06-Mar-2021, FATIGUE (very tired) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), BODY TEMPERATURE ABNORMAL (temp 102.1°F), FEELING ABNORMAL (didn't feel well), PAIN (hurt), NAUSEA (very nauseated) and PAIN (aches like she had the flu all day) outcome was unknown and HEADACHE (terrible headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 102.1 (High) 102.1°F. On 06-Mar-2021, Body temperature: 100 100 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Headache, Myalgia, Nausea
Clinical narrative: Clamminess; muscle pain; Chills; Nausea; Splitting headache turned into body pains; splitting headache; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Clamminess), MYALGIA (muscle pain), HEADACHE (splitting headache), CHILLS (Chills) and NAUSEA (Nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (splitting headache) and MYALGIA (Splitting headache turned into body pains). On an unknown date, the patient experienced COLD SWEAT (Clamminess), MYALGIA (muscle pain), CHILLS (Chills) and NAUSEA (Nausea). On 06-Mar-2021, HEADACHE (splitting headache) had resolved. At the time of the report, COLD SWEAT (Clamminess), MYALGIA (muscle pain), CHILLS (Chills), NAUSEA (Nausea) and MYALGIA (Splitting headache turned into body pains) outcome was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: felt like had a really bad case of the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like had a really bad case of the flu) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (felt like had a really bad case of the flu). At the time of the report, INFLUENZA LIKE ILLNESS (felt like had a really bad case of the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash pruritic
Clinical narrative: Reaction two weeks post injection which resulted in a red, itchy rash; Reaction two weeks post injection which resulted in a red, itchy rash; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH PRURITIC (Reaction two weeks post injection which resulted in a red, itchy rash) and ERYTHEMA (Reaction two weeks post injection which resulted in a red, itchy rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Reaction two weeks post injection which resulted in a red, itchy rash) and ERYTHEMA (Reaction two weeks post injection which resulted in a red, itchy rash). At the time of the report, RASH PRURITIC (Reaction two weeks post injection which resulted in a red, itchy rash) and ERYTHEMA (Reaction two weeks post injection which resulted in a red, itchy rash) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicines were reported Reportedly, the patient was advised to take some diphenhydramine (Benadryl).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Erythema, Flushing
Clinical narrative: face on one side is getting flushed; hot; red; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (face on one side is getting flushed), DRY SKIN (hot) and ERYTHEMA (red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015MZ0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN 81), BUSPIRONE, DULOXETINE, EZETIMIBE, PANTOPRAZOLE, GABAPENTIN, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), PYRIDOXINE, THIAMINE (VITAMIN B1 AND B6), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), MELATONIN, CALCIUM 600 + D3 PLUS MINERALS, PROBIOTIC 10 and TRIAMCINOLONE ACETONIDE (NASACORT) for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FLUSHING (face on one side is getting flushed), DRY SKIN (hot) and ERYTHEMA (red). At the time of the report, FLUSHING (face on one side is getting flushed), DRY SKIN (hot) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Feeling abnormal, Headache, Illness, Pain in extremity
Clinical narrative: sore arm; left boob was very tender; feeling lousy; kind of sick; really bad headache; wasn't given properly/not clear of how much I got; put the needle in, took it out, put it back in; bleeding; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in), UNDERDOSE (wasn't given properly/not clear of how much I got), VACCINATION SITE HAEMORRHAGE (bleeding), PAIN IN EXTREMITY (sore arm) and BREAST TENDERNESS (left boob was very tender) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was reported. .    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in), UNDERDOSE (wasn't given properly/not clear of how much I got) and VACCINATION SITE HAEMORRHAGE (bleeding). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), BREAST TENDERNESS (left boob was very tender), FEELING ABNORMAL (feeling lousy), ILLNESS (kind of sick) and HEADACHE (really bad headache). On 30-Jan-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in) and UNDERDOSE (wasn't given properly/not clear of how much I got) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (bleeding), PAIN IN EXTREMITY (sore arm), BREAST TENDERNESS (left boob was very tender), FEELING ABNORMAL (feeling lousy), ILLNESS (kind of sick) and HEADACHE (really bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter. patient mentioned ice cold running down her arm until her fingers, unclear of how much serum she got in her body.    This case was linked to MOD-2021-039117, MOD-2021-231750, MOD-2021-231750 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: TCR : Details of Doses, AE outcome; Sender's Comments: This report refers to a case of Wrong injection technique  and underdose for mRNA-1273  with  associated AEs, based on available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  .
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose, Vaccination site haemorrhage, Wrong technique in product usage process
Clinical narrative: sore arm; left boob was very tender; feeling lousy; kind of sick; really bad headache; wasn't given properly/not clear of how much I got; put the needle in, took it out, put it back in; bleeding; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in), UNDERDOSE (wasn't given properly/not clear of how much I got), VACCINATION SITE HAEMORRHAGE (bleeding), PAIN IN EXTREMITY (sore arm) and BREAST TENDERNESS (left boob was very tender) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was reported. .    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in), UNDERDOSE (wasn't given properly/not clear of how much I got) and VACCINATION SITE HAEMORRHAGE (bleeding). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), BREAST TENDERNESS (left boob was very tender), FEELING ABNORMAL (feeling lousy), ILLNESS (kind of sick) and HEADACHE (really bad headache). On 30-Jan-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (put the needle in, took it out, put it back in) and UNDERDOSE (wasn't given properly/not clear of how much I got) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (bleeding), PAIN IN EXTREMITY (sore arm), BREAST TENDERNESS (left boob was very tender), FEELING ABNORMAL (feeling lousy), ILLNESS (kind of sick) and HEADACHE (really bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter. patient mentioned ice cold running down her arm until her fingers, unclear of how much serum she got in her body.    This case was linked to MOD-2021-039117, MOD-2021-231750, MOD-2021-231750 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: TCR : Details of Doses, AE outcome; Sender's Comments: This report refers to a case of Wrong injection technique  and underdose for mRNA-1273  with  associated AEs, based on available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  .
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Dyspepsia, Nasal congestion, Product dose omission issue
Clinical narrative: She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine; Tested positive for the COVID-19 virus; Some congestion; Digestive system was messed up for one day; Slight fever, 100.5 degrees Fahrenheit; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion), DYSPEPSIA (Digestive system was messed up for one day), PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 02-Feb-2021.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PYREXIA (Slight fever, 100.5 degrees Fahrenheit). On 02-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion) and DYSPEPSIA (Digestive system was messed up for one day). On 22-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine). On 22-Feb-2021, PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus) and DYSPEPSIA (Digestive system was messed up for one day) had resolved and NASAL CONGESTION (Some congestion) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Body temperature increased: 100.5 (High) 100.5. On 02-Feb-2021, COVID-19: positive (Positive) Positive.         The patient had her 2nd dose of moderna vaccine on april2021 and was reported  that she did not have any side effects from her second vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: No specific follow-up information recorded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The possible exposure to COVID-19 virus was a strong confounder.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine; Tested positive for the COVID-19 virus; Some congestion; Digestive system was messed up for one day; Slight fever, 100.5 degrees Fahrenheit; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion), DYSPEPSIA (Digestive system was messed up for one day), PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 02-Feb-2021.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PYREXIA (Slight fever, 100.5 degrees Fahrenheit). On 02-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus), NASAL CONGESTION (Some congestion) and DYSPEPSIA (Digestive system was messed up for one day). On 22-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine). On 22-Feb-2021, PRODUCT DOSE OMISSION ISSUE (She could not make her second appointment of 22Feb2021 to receive her second dose of the vaccine) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for the COVID-19 virus) and DYSPEPSIA (Digestive system was messed up for one day) had resolved and NASAL CONGESTION (Some congestion) and PYREXIA (Slight fever, 100.5 degrees Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Body temperature increased: 100.5 (High) 100.5. On 02-Feb-2021, COVID-19: positive (Positive) Positive.         The patient had her 2nd dose of moderna vaccine on april2021 and was reported  that she did not have any side effects from her second vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: No specific follow-up information recorded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The possible exposure to COVID-19 virus was a strong confounder.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia, Vision blurred
Clinical narrative: blurred vison; headache; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vison), HEADACHE (headache) and MYALGIA (muscle aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke in 2014.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vison), HEADACHE (headache) and MYALGIA (muscle aches). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 325 milligram. At the time of the report, VISION BLURRED (blurred vison), HEADACHE (headache) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. Patient took .Aspirin 325mg as a treatment drug
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Illness, Migraine, Pain in extremity, Pruritus
Clinical narrative: Itching started on the right side of the body from shoulder to foot; having no energy and could hardly move; felt not his best/terrible and sick described as having no energy and could hardly move; headache suspected as migraine headache; sore arm muscle near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm muscle near the injection site), ILLNESS (felt not his best/terrible and sick described as having no energy and could hardly move), MIGRAINE (headache suspected as migraine headache), PRURITUS (Itching started on the right side of the body from shoulder to foot) and ASTHENIA (having no energy and could hardly move) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Benadryl), Penicillin allergy and Blood pressure (Patient is taking bloodpressure medication.). Concomitant products included FINASTERIDE and TAMSULOSIN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm muscle near the injection site). On 27-Feb-2021, the patient experienced ILLNESS (felt not his best/terrible and sick described as having no energy and could hardly move), MIGRAINE (headache suspected as migraine headache) and ASTHENIA (having no energy and could hardly move). On 28-Feb-2021, the patient experienced PRURITUS (Itching started on the right side of the body from shoulder to foot). On 28-Feb-2021, MIGRAINE (headache suspected as migraine headache) had resolved. On 04-Mar-2021, ILLNESS (felt not his best/terrible and sick described as having no energy and could hardly move) and ASTHENIA (having no energy and could hardly move) had resolved. On 05-Mar-2021, PAIN IN EXTREMITY (sore arm muscle near the injection site) and PRURITUS (Itching started on the right side of the body from shoulder to foot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Product includes Blood Pressure Medication.   Treatment includes rubbing alcohol to the itching areas.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Paraesthesia
Clinical narrative: numbness of face; tingling of face; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness of face), PARAESTHESIA (tingling of face) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN and MELOXICAM for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HYPOAESTHESIA (numbness of face), PARAESTHESIA (tingling of face) and HEADACHE (headache). At the time of the report, HYPOAESTHESIA (numbness of face), PARAESTHESIA (tingling of face) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included SERTRALINE for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, COVID-19: positive (Positive) tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.